About Virupaksha
Virupaksha is a company based in Hyderabad (India) founded in 2003 by Chandra Mouliswar Reddy Gangavaram. Virupaksha has raised $12.8 million across 1 funding round from investors including Chappidi Sudhakar Reddy, Chappidi Sailaja and Venkata Subba Reddy. The company has 708 employees as of September 28, 2024. Virupaksha offers products and services including Pharmaceutical Solutions and Fine Chemical Solutions.
- Headquarter Hyderabad, India
- Employees 708 as on 28 Sep, 2024
- Founders Chandra Mouliswar Reddy Gangavaram
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Virupaksha Organics Ltd
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$59.76 M (USD)4.07as on Mar 31, 2022
-
Net Profit
$2.82 M (USD)-54.41as on Mar 31, 2022
-
EBITDA
$5.78 M (USD)-44.59as on Mar 31, 2022
-
Total Equity Funding
$12.8 M (USD)
in 1 rounds
-
Latest Funding Round
$12.8 M (USD), Series B
Jul 18, 2024
-
Investors
Gavva Consultancy
& 163 more
-
Employee Count
708
as on Sep 28, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Virupaksha
Virupaksha offers a comprehensive portfolio of products and services, including Pharmaceutical Solutions and Fine Chemical Solutions.
Pharmaceutical solutions are manufactured and supplied for medical applications by the company.
Fine chemical solutions are produced and distributed for industrial uses by the company.
People of Virupaksha
Unlock access to complete
Funding Insights of Virupaksha
Virupaksha has successfully raised a total of $12.8M through 1 strategic funding round. The most recent funding activity was a Series B round of $12.8 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $12.8M
-
First Round
First Round
(18 Jul 2024)
- Investors Count 164
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2024 | Amount | Series B - Virupaksha | Valuation | Chappidi Sudhakar Reddy , Chappidi Sailaja |
Investors in Virupaksha
Virupaksha has secured backing from 164 investors, including angel and institutional investors. Prominent investors backing the company include Chappidi Sudhakar Reddy, Chappidi Sailaja and Venkata Subba Reddy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Manufactures and supplies Active Pharmaceutical Ingredients and intermediates for global markets.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
Investments & Acquisitions by Virupaksha
Financial Statements - Virupaksha
Virupaksha Comparisons
Competitors of Virupaksha
Frequently Asked Questions about Virupaksha
Virupaksha was founded in 2003 and raised its 1st funding round 21 years after it was founded.
Virupaksha is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Virupaksha is a funded company, having raised a total of $12.8M across 1 funding round to date. The company's 1st funding round was a Series B of $12.8M, raised on Jul 18, 2024.
As of Sep 28, 2024, the latest employee count at Virupaksha is 708.
Annual revenue of Virupaksha is $59.76M as on Mar 31, 2022.
Virupaksha was founded in 2003 and is headquartered in Hyderabad, India. Active pharmaceutical ingredients (APIs) and intermediates are produced by the company within the pharmaceutical sector. Manufacturing operations are centered on these core products, supporting supply chains for drug development. The facility in Hyderabad handles production processes, with oversight from founder and managing director Chandra Mouliswar Reddy Gangavaram. Domain presence is maintained at virupaksha.com.
Virupaksha offers Pharmaceutical Solutions and Fine Chemical Solutions.
Virupaksha has 164 investors. Key investors include Chappidi Sudhakar Reddy, Chappidi Sailaja, Venkata Subba Reddy, Rajmohan Reddy, and Jaya Kiran Reddy.